// App-Quantinova.ai

2236 : Long lasting CR status of stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine (AFTV)

Researchers

Presenter

  • Fumito Kuranishi

Principal Investigators

  • Yusuke Sumi

  • yoij Uemae

  • Tadao Ohno

Medical Centers

  • Innoshima Ishikai Hospital, Onomichi, Japan

  • Cell-medicine Inc.,, Tsukuba, Japan.

Locations

  • Japan

Companies

  • Cell-Medicine, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gallbladder cancer

  • Bone metastases

  • Lung Cancer

  • Bladder Cancer

  • Breast cancer

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved